69 studies found for:    Open Studies | "Pigmentation Disorders"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pigmentation Disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
Conditions: Surgical Wound;   Hypo-pigmented Skin
Intervention: Device: Momelan Technologies Epidermal Graft Harvesting System
2 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:
3 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
4 Recruiting Study of Mast Cell Precursors
Conditions: Normal Physiology;   Systemic Mastocytosis
Intervention:
5 Recruiting Photocil (Topical) for the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Photocil for Vitiligo;   Other: Placebo - Sunscreen (SPF 2)
6 Recruiting Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Condition: Lentigo Maligna Melanoma (Head or Neck)
Interventions: Drug: Imiquimod cream + surgery;   Drug: vehicle + surgery
7 Recruiting A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
Conditions: Vitiligo;   Piebaldism
Interventions: Device: VITICELL;   Device: PLACEBO
8 Unknown  Azelaic Acid Versus Hydroquinone in Melasma
Condition: Melanosis
Interventions: Drug: azelaic acid gel;   Drug: hydroquinone cream
9 Unknown  Treatment and Complication of Bath PUVA in Vitiligo
Condition: Vitiligo
Intervention: Device: Bath PUVA
10 Unknown  Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
Condition: Kidney Failure, Chronic
Intervention: Drug: vitamin C, intravenous injection
11 Recruiting Clinical and Basic Investigations Into Erdheim Chester Disease
Conditions: Myelofibrosis;   Gaucher Disease;   Pulmonary Fibrosis;   Hermansky-Pudlak Syndrome (HPS);   Cancer
Intervention:
12 Not yet recruiting Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity
Condition: Acanthosis Nigricans
Interventions: Drug: Metformin;   Other: Placebo
13 Not yet recruiting Fractional Laser in Combination With UVB Therapy in Vitiligo Patients
Condition: Vitiligo
Interventions: Device: Fractional CO2 laser;   Other: NB-UVB therapy;   Drug: Fluticasone Propionate Cream 0.05%
14 Not yet recruiting Radiotherapy or Imiquimod in Complex Lentigo Maligna
Condition: Lentigo Maligna
Interventions: Drug: Imiquimod;   Radiation: Radiotherapy
15 Not yet recruiting Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Interventions: Other: Pancreatic Cancer Screening Pathway 1;   Other: Pancreatic Cancer Screening Pathway 2
16 Unknown  Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol
Condition: Vitiligo
Interventions: Genetic: Sequential phototherapy;   Procedure: Continuous phototherapy
17 Recruiting UVA 1 Phototherapy for Vitiligo
Condition: Vitiligo
Intervention: Procedure: UVA1
18 Recruiting Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
Conditions: Aggressive Systemic Mastocytosis (ASM);   Systemic Mastocytosis With Associated Clonal Hematological Non-mast Cell Lineage Disease (SM-AHNMD);   Mast Cell Leukemia (MCL);   Smoldering Systemic Mastocytosis (SSM);   Indolent Systemic Mastocytosis (ISM) [ISM Subgroup Fully Recruited]
Intervention: Other: Interview
19 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
20 Recruiting A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Aplastic Anemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Essential Thrombocythemia;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Juvenile Myelomonocytic Leukemia;   Mastocytosis;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Polycythemia Vera;   Previously Treated Myelodysplastic Syndromes;   Primary Myelofibrosis;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Anemia;   Refractory Anemia With Ringed Sideroblasts;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   T-cell Large Granular Lymphocyte Leukemia;   Waldenström Macroglobulinemia
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Radiation: Total Body Irradiation (TBI);   Biological: Donor Lymphocyte Infusion (DLI);   Drug: Cyclophosphamide (CY);   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Device: Allogeneic hematopoietic stem cell transplantation;   Procedure: Peripheral blood stem cell transplantation (PBSCT)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years